{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:13:40Z","timestamp":1793171620166,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012576","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110486","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:36:23Z","timestamp":1788849383000},"page":"110486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Heterobivalent fibroblast activation protein\u2013targeted Radiotheranostic ligands integrating cyclic peptide and small-molecule motifs for enhanced tumor retention"],"prefix":"10.1016","volume":"182","author":[{"given":"Baocheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruitao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongzhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioorg.2026.110486_bb0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Xueman","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110486_bb0010","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Xiaoqi, Mao; Jin, Xu; Wei, Wang; Chen, Liang; Jie, Hua; Jiang, Liu; Bo, Zhang; Qingcai, Meng; Xianjun, Yu; Si, Shi","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.110486_bb0015","doi-asserted-by":"crossref","unstructured":"Allison A, Fitzgerald; Louis M, Weiner. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39(3):783\u2013803. Doi: https:\/\/doi.org\/10.1007\/s10555-020-09909-3.","DOI":"10.1007\/s10555-020-09909-3"},{"issue":"32","key":"10.1016\/j.bioorg.2026.110486_bb0020","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","article-title":"Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics","volume":"37","author":"Ellen","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110486_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2967\/jnumed.119.241232","article-title":"FAP: the next billion dollar nuclear theranostics target?","volume":"61","author":"Jeremie","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"0","key":"10.1016\/j.bioorg.2026.110486_bb0030","article-title":"FAPI-PET\/CT in cancer imaging: a potential novel molecule of the century","volume":"12","author":"Rong, Huang; Yu, Pu; Shun, Huang; Conghui, Yang; Fake, Yang; Yongzhu, Pu; Jindan, Li; Long, Chen; Yunchao, Huang","year":"2022","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110486_bb0035","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Thomas","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110486_bb0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2967\/jnumed.120.259192","article-title":"Feasibility, biodistribution, and preliminary dosimetry in peptide-targeted radionuclide therapy of diverse adenocarcinomas using 177Lu-FAP-2286: first-in-humans results","volume":"63","author":"Richard P","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110486_bb0045","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00259-021-05653-0","article-title":"Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA","volume":"49","author":"P","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110486_bb0050","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00259-020-05132-y","article-title":"Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET\/CT in patients with various cancers","volume":"48","author":"Sanjana","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bioorg.2026.110486_bb0055","doi-asserted-by":"crossref","unstructured":"Sanjana, Ballal; Madhav Prasad, Yadav; Euy Sung, Moon; Frank, Roesch; Samta, Kumari; Shipra, Agarwal; Madhavi, Tripathi; Ranjit Kumar, Sahoo; Bharadwaj Srinivas, Mangu; Avinash, Tupalli; Chandrasekhar, Bal. Novel fibroblast activation protein inhibitor-based targeted theranostics for radioiodine-refractory differentiated thyroid cancer patients: a pilot study. Thyroid 2022;32(1):65\u201377. Doi: https:\/\/doi.org\/10.1089\/thy.2021.0412.","DOI":"10.1089\/thy.2021.0412"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110486_bb0060","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1007\/s00259-022-05757-1","article-title":"18F- or 177Lu-labeled bivalent ligand of fibroblast activation protein with high tumor uptake and retention","volume":"49","author":"Hongsheng, Li; Shimin, Ye; Li Li; Jiawei, Zhong; Qingsong, Yan; Yuhua, Zhong; Pengju, Feng; Kongzhen, Hu","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110486_bb0065","first-page":"476","article-title":"Fibroblast activation protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time","volume":"11","author":"Euy Sung, Moon; Sanjana, Ballal; Madhav Prasad, Yadav; Chandrasekhar, Bal; Yentl, Van Rymenant; Sarah, Stephan; An, Bracke; Pieter, Van der Veken; Ingrid, De Meester; Frank, Roesch","year":"2021","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110486_bb0070","article-title":"Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators","volume":"5","author":"Euy Sung, Moon; Filipe, Elvas; Gwendolyn, Vliegen; Stef, De Lombaerde; Christel, Vangestel; Sven, De Bruycker; An, Bracke; Elisabeth, Eppard; Lukas, Greifenstein; Benedikt, Klasen; Vasko, Kramer; Steven, Staelens; Ingrid, De Meester; Pieter, Van der Veken; Frank, R\u00f6sch","year":"2020","journal-title":"EJNMMI Radiopharm. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110486_bb0075","article-title":"In vitro evaluation of the squaramide-conjugated fibroblast activation protein inhibitor-based agents AAZTA5.SA.FAPi and DOTA.SA.FAPi","volume":"26","author":"Euy Sung, Moon; Yentl, Van Rymenant; Sandeep, Battan; Joni, De Loose; An, Bracke; Pieter, Van der Veken; Ingrid, De Meester; Frank, R\u00f6sch","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110486_bb0080","first-page":"1","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Siqi, Zhang; Xingkai, Wang; Xin, Gao; Xueyao, Chen; Linger, Li; Guoqing, Li; Can, Liu; Yuan, Miao; Rui, Wang; Kuan, Hu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110486_bb0085","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","author":"Anastasia, Loktev; Thomas, Lindner; Walter, Mier; J\u00fcrgen, Debus; Annette, Altmann; Dirk, J\u00e4ger; Frederik, Giesel; Clemens, Kratochwil; Philippe, Barthe; Christian, Roumestand; Uwe, Haberkorn","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110486_bb0090","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","article-title":"Development of fibroblast activation protein-targeted radiotracers with improved tumor retention","volume":"60","author":"Anastasia, Loktev; Thomas, Lindner; Eva-Maria, Burger; Annette, Altmann; Frederik, Giesel; Clemens, Kratochwil; J\u00fcrgen, Debus; Frederik, Marm\u00e9; Dirk, J\u00e4ger; Walter, Mier; Uwe, Haberkorn","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110486_bb0095","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","article-title":"Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy","volume":"49","author":"Dirk, Zboralski; Aileen, Hoehne; Anne, Bredenbeck; Anne, Schumann; Minh, Nguyen; Eberhard, Schneider; Jan, Ungewiss; Matthias, Paschke; Christian, Haase; Jan L, von Hacht; Tanya, Kwan; Kevin K, Lin; Jan, Lenore; Thomas C, Harding; Jim, Xiao; Andrew D, Simmons; Ajay-Mohan, Mohan; Nicola, Beindorff; Ulrich, Reineke; Christiane, Smerling; Frank, Osterkamp","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"0","key":"10.1016\/j.bioorg.2026.110486_bb0100","article-title":"Advancing fibroblast activation protein inhibitors for targeted radioligand therapy: strategies and innovations to increase tumor residence time","volume":"309","author":"Simona","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110486_bb0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2967\/jnumed.123.266345","article-title":"Preclinical development of PNT6555, a boronic acid-based, fibroblast activation protein-\u03b1 (FAP)-targeted radiotheranostic for imaging and treatment of FAP-positive tumors","volume":"65","author":"Sarah E, Poplawski; Robin M, Hallett; Mark H, Dornan; Kyle E, Novakowski; Shuang, Pan; Anthony P, Belanger; Quang-De, Nguyen; Wengen, Wu; Albert E, Felten; Yuxin, Liu; Shin Hye, Ahn; Valerie S, Hergott; Barry, Jones; Jack H, Lai; Joe A B, McCann; William W, Bachovchin","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110486_bb0110","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2967\/jnumed.121.263016","article-title":"Synthesis, preclinical evaluation, and a pilot clinical PET imaging study of 68Ga-labeled FAPI dimer","volume":"63","author":"Liang, Zhao; Bo, Niu; Jianyang, Fang; Yizhen, Pang; Siyang, Li; Chengrong, Xie; Long, Sun; Xianzhong, Zhang; Zhide, Guo; Qin, Lin; Haojun, Chen","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110486_bb0115","article-title":"Radiosynthesis and preclinical evaluation of bispecific PSMA\/FAP heterodimers for tumor imaging","volume":"15","author":"Kongzhen","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110486_bb0120","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2967\/jnumed.122.264036","article-title":"A dimeric FAP-targeting small-molecule radioconjugate with high and prolonged tumor uptake","volume":"63","author":"Andrea, Galbiati; Aureliano, Zana; Matilde, Bocci; Jacopo, Millul; Abdullah, Elsayed; Jacqueline, Mock; Dario, Neri; Samuele, Cazzamalli","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110486_bb0125","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2967\/jnumed.121.263292","article-title":"PET with a 68Ga-labeled FAPI dimer: moving toward theranostics","volume":"63","author":"Muhsin H, Younis; Xiaoli, Lan; Weibo, Cai","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110486_bb0130","first-page":"537","article-title":"Dimeric FAPI with potential for tumor theranostics","volume":"11","author":"Chunxia, Qin; Yangmeihui, Song; Weibo, Cai; Xiaoli, Lan","year":"2021","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110486_bb0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-025-01230-w","article-title":"A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein","volume":"15","author":"Chengde, Xie; Lei, Peng; Hui, Nie; Tianhong, Yang; Renbo, Wu; Dake, Zhang; Fuhua, Wen; Junyu, Chen; Lingyu, Xue; Xiangsong, Zhang; Zhihao, Zha; Jianjun, Wang","year":"2025","journal-title":"EJNMMI Res."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110486_bb0140","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1021\/acsptsci.6c00120","article-title":"Head-to-head comparison of monomeric, homodimeric, and heterodimeric fibroblast activation protein-targeting radioligands based on small molecule inhibitor and cyclic peptide","volume":"9","author":"Kosuke, Saito; Hiroyuki, Watanabe; Kazuma, Nakashima; Masahiro, Ono","year":"2026","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110486_bb0145","article-title":"Synthesis and preclinical evaluation of novel 68Ga-labeled (R)-pyrrolidin-2-yl-boronic acid-based PET tracers for fibroblast activation protein-targeted cancer imaging","volume":"16","author":"Shreya","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110486_bb0150","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/mp060049x","article-title":"Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging","volume":"3","author":"Shuang","year":"2006","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110486_bb0155","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1021\/bc900167c","article-title":"Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency","volume":"20","author":"Shuang","year":"2009","journal-title":"Bioconjug. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110486_bb0160","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1039\/C4SC00685B","article-title":"A bivalent small molecule-drug conjugate directed against carbonic anhydrase IX can elicit complete tumour regression in mice","volume":"5","author":"N, Krall; F, Pretto; D, Neri","year":"2014","journal-title":"Chem. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110486_bb0165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2967\/jnumed.124.267547","article-title":"Are FAP theranostics really happening? Will radiochemistry or biology win?","volume":"66","author":"Rodney","year":"2025","journal-title":"J. Nucl. Med."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110486_bb0170","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1021\/acs.jmedchem.4c00544","article-title":"Rational design and pharmacomodulation of 18F-labeled biotin\/FAPI-conjugated heterodimers","volume":"67","author":"Xuedong, Chen; Dongsheng, Xia; Xueyuan, Zeng; Lingxin, Meng; Yanjie, Wang; Huifeng, Li; Jingru, Zhang; Zuoquan, Zhao; Rongqiang, Zhuang; Jianyang, Fang; Xianzhong, Zhang; Zhide, Guo","year":"2024","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110486_bb0175","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/acs.molpharmaceut.1c00932","article-title":"Design and evaluation of novel albumin-binding folate radioconjugates: systematic approach of varying the linker entities","volume":"19","author":"Martina, Bene\u0161ov\u00e1; Patrycja, Guzik; Luisa M, Deberle; Sarah D, Busslinger; Tanja, Landolt; Roger, Schibli; Cristina, M\u00fcller","year":"2022","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110486_bb0180","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C3CS60304K","article-title":"Matching chelators to radiometals for radiopharmaceuticals","volume":"43","author":"Eric W, Price; Chris, Orvig","year":"2014","journal-title":"Chem. Soc. Rev."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110486_bb0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13139-025-00935-z","article-title":"Fibroblast activation protein-targeted theranostics: current status in clinical development","volume":"59","author":"Yeon-Koo","year":"2025","journal-title":"Nucl. Med. Mol. Imaging"},{"issue":"0","key":"10.1016\/j.bioorg.2026.110486_bb0190","article-title":"Development and characterization of novel FAP-targeted theranostic pairs: a bench-to-bedside study","volume":"6","author":"Wei","year":"2023","journal-title":"Research (Wash D C)"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110486_bb0195","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1021\/acs.jmedchem.5c00890","article-title":"Deciphering the tumor uptake of heterobivalent (SST(2)\/albumin) [64Cu]cu-NODAGA-cLAB-TATEs","volume":"68","author":"Florian","year":"2025","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110486_bb0200","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1039\/D5CC06620D","article-title":"Dual pharmacokinetic modifier strategy for synergistically enhanced tumor accumulation of PSMA-targeting radioligand","volume":"62","author":"Takuma","year":"2026","journal-title":"Chem. Commun. (Camb.)"},{"issue":"14","key":"10.1016\/j.bioorg.2026.110486_bb0205","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.7150\/thno.100091","article-title":"The heterobivalent (SSTR2\/albumin) radioligand [67Cu]cu-NODAGA-cLAB4-TATE enables efficient somatostatin receptor radionuclide theranostics","volume":"14","author":"Martin","year":"2024","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110486_bb0210","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.apsb.2021.09.032","article-title":"Preclinical evaluation and pilot clinical study of [18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts","volume":"12","author":"Kongzhen","year":"2022","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:26:24Z","timestamp":1791260784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826010229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0045206826010229"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110486","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterobivalent fibroblast activation protein\u2013targeted Radiotheranostic ligands integrating cyclic peptide and small-molecule motifs for enhanced tumor retention","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110486"}}